Board of Directors

Print Page | Email Friend

Peter Goodhand
President & CEO

Canadian Cancer Society National Office
10 Alcorn Avenue, Suite 200
Toronto, Ontario M4V 3B1
T: (416) 961-7223 |  F: (416) 961-4189
E: pgoodhand@cancer.ca

Chairman, Board of Directors
Chairman, HTX National Advisors to the Board of Directors

Peter has been involved in the Medical Device industry for over 20 years. He moved through progressive sales and marketing management roles in the U.K. before moving to New Jersey as International Product Manager for Cyanamid. Read more about Peter Goodhand.


 

Phil Spencer

Phil Spencer
Q.C

Cassels Brock
2100 Scotia Plaza
40 King Street West
Toronto, ON   M5H 3C2
Tel: (416) 860-2978 | Fax: (416) 640-3155
E-mail: pspencer@casselsbrock.com

Secretary, Board of Directors

Phil is a member of Cassels Brock's Health Law Group. His practice is focused on the life sciences and he works principally in pharmaceuticals, medical devices and medical technology. Read more about Phil Spencer.


 

Gary Hodgins
President

Pharmax Limited 80 Galaxy Boulevard, Unit 4
Toronto, ON   M9W 4Y8
Tel: (416) 675-3333 | Fax: (416) 675-9176
E-mail: ghodgins@pharmax.ca

Treasurer, Board of Directors

Treasurer, HTX National Advisors to the Board of Directors

Gary is President and CEO of Pharmax Limited, privately-held global manufacturer of infection control solutions. Pharmax is dedicated to the manufacture of market-leading products and development of market-transforming ideas, leading to higher performance standards in infection prevention and control. Read more about Gary Hodgins.


 

David Ames
Director of Emerging Technologies and 
Health Economics

Johnson & Johnson Medical Products 
200 Whitehall Drive
Markham, ON   L3R OT5
Tel: (905) 946-8999       
E-mail: dames@medca.jnj.com

Member, Board of Directors

David Ames is the Director of Health Technology Assessment and Medical Affairs for Johnson & Johnson Medical Products in Canada.  Read more about David Ames.


 

Ken Lawless
President

Epitope Capital Corp
6143 Lariviere Crescent
Ottawa, ON   K1W 1C6
Tel: (613) 834-0413   
E-mail: ken.lawless@rogers.com

Member, Board of Directors

Ken Lawless was the founding president of the OLSC since its inception in May 1994 until June 2006 when it became OCRI. The Council is a not-for-profit development corporation for the life sciences sector. Read more about Ken Lawless.


 

Michael Sefton
Professor

Institute of Biomaterials and Biomedical Engineering, University of Toronto
Rosebrugh Building, Room 407
164 College Street, Toronto, ON   M5S 3G9
Tel: (416) 978-3088 | Fax: (416) 978-4317
E-mail: michael.sefton@utoronto.ca

Member, Board of Directors

Dr. Sefton's research specialization includes tissue engineering, biomaterials and cell transplantation and drug delivery. In the field of tissue engineering, he has been leading the Toronto effort to build a multi-disciplinary team of researchers including basic scientists, engineers and clinicians to advance the basic understanding of this emerging field and address specific clinical problems such as nerve regeneration, artificial skin and cardiac replacement. Read more about Michael Sefton.


 

David Shindler
Executive Director

BioDiscovery Toronto
MaRS Convergence Centre
101 College Street
Toronto, ON   M5G 1L7
Tel: (416) 673-8475   
E-mail: dshindler@biodiscovery.ca

Member, Board of Directors

Dr. Shindler has recently been appointed as Executive Director of BioDiscovery Toronto. BioDiscovery Toronto comprises 9 of Toronto's leading research universities and hospital research institutes, and has a mandate to enhance technology transfer and commercialization based on Toronto's world-class biomedical research. Read more about David Shindler.